Which company developed Selpercatinib/Selpercatinib?
SelpercatinibByLoxo Oncology (Eli Lilly and Company)Developed and produced for patients with locally advanced non-small cell lung cancer(non-small cell lung cancer) or non-small cell lung cancer that has spread. For use in adults and children 12 years and older with medullary thyroid cancer (MTC) or MTC that has spread. For use in adults and children 12 years of age and older with thyroid cancer or patients with spread thyroid cancer who require oral or injectable medications (systemic treatment), and patients who have received radioactive iodine therapy but it has failed or is no longer effective. Also used for patients with locally advanced solid tumors(cancer)or solid tumors that have spread and have gotten worse(worsened) during or after other treatments,or for which there are no satisfactory treatment options.

Tell your doctor about all the medications you are taking, including prescription and over-the-counter drugs, vitamins, and herbal supplements. Certain other medicines may affect how serpatinib works. The following drugs should be avoided during treatment with Sepretinib/Selpatinib: St. John's wort, Proton pump inhibitors(Proton pump inhibitors, such as dexlansoprazole, esomeprazole Azole, lansoprazole, omeprazole, pantoprazole sodium, rabeprazole), H2blockers(such as famotidine, nizatidine, and cimetidine), and antacids containing aluminum, magnesium, calcium, simethicone, or buffered drugs. If you are taking a proton pump inhibitor(PPI, such as dexlansoprazole, esomeprazole, lansoprazole, omeprazole, pantoprazole sodium, and rabeprazole
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)